Dimenoxadol

This classification denotes an analgesic agent with the molecular formula C20H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4D65PBX0VK, chemically known as 2-dimethylaminoethyl 1-ethoxy-1,1-diphenylacetate but generally known as dimenoxadol, which bears US NIH Compound Identifier 17036. European Medicines Agency schedules Dimenoxadol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07160MIG. The term DIMENOXADOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). DIMENOXADOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dimenoxadol under HS 29221980 and SITC 51461. As of Q4 2014, DIMENOXADOL remains the US FDA Preferred Term for this commodity. Dimenoxadol bears US NLM identifiers UMLS ID C0058194 and NCI Concept Code C65400. SMILES: O(C(C1CCCCC1)(C1CCCCC1)C(=O)OCCN(C)C)CC.